The glycine peak in brain diseases

Publisher： Elsevier

ISSN： 0895-6111

Source： Computerized Medical Imaging and Graphics, Vol.27, Iss.4, 2003-07, pp. : 297-305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Aberrant protein structure and diseases of the brain

By Welzel A.

Irish Journal of Medical Science, Vol. 180, Iss. 1, 2011-03 ,pp. : 15-22

Springer Publishing Company

Access to resources Recommend Favorite

Role of lipids in brain injury and diseases

By Adibhatla Rao Muralikrishna Hatcher James F

Future Lipidology, Vol. 2, Iss. 4, 2007-08 ,pp. : 403-422

Future Medicine

Access to resources Recommend Favorite

The Neuroprotective Effect and Probable Mechanism of DL-3-n-Butylphthalide in Brain Diseases

Integrative Medicine International, Vol. 1, Iss. 1, 2014-06 ,pp. : 51-55

Karger

Access to resources Recommend Favorite

Are Mental Disorders Brain Diseases, and What Does This Mean? A Clinical-Neuropsychological Perspective

Psychopathology, Vol. 49, Iss. 3, 2016-07 ,pp. : 135-142

Karger

Access to resources Recommend Favorite

Synthetic nucleic acids delivered by exosomes: a potential therapeutic for generelated metabolic brain diseases

By Liu Rutao Liu Jing Ji Xiaofei Liu Yang

Metabolic Brain Disease, Vol. 28, Iss. 4, 2013-12 ,pp. : 551-562

Springer Publishing Company

Access to resources Recommend Favorite